{{Rsnum
|rsid=973968
|Chromosome=14
|position=62187980
|Orientation=plus
|GMAF=0.1451
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 69.0 | 28.3 | 2.7
| HCB | 91.2 | 8.8 | 0.0
| JPT | 85.0 | 15.0 | 0.0
| YRI | 53.7 | 38.1 | 8.2
| ASW | 54.4 | 38.6 | 7.0
| CHB | 91.2 | 8.8 | 0.0
| CHD | 92.7 | 7.3 | 0.0
| GIH | 84.2 | 15.8 | 0.0
| LWK | 69.1 | 26.4 | 4.5
| MEX | 74.1 | 24.1 | 1.7
| MKK | 71.2 | 24.4 | 4.5
| TSI | 81.4 | 16.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000003
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs973968
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 411 family members; Replication Sample Size: NR); (Region: 14q23.2; Reported Gene(s): Q6ZUR9; Risk Allele: rs973968-?); (p-value= 0.000003).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740124
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs973968
|overall_frequency_n=107
|overall_frequency_d=128
|overall_frequency=0.835938
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=92
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}